Development of hematopoietic stem and progenitor cells from human pluripotent stem cells

Journal of Cellular Biochemistry
Tong ChenZack Z Wang

Abstract

Human pluripotent stem cells (hPSCs), including human embryonic stem cells (hESCs) and human induced pluripotent stem cells (hiPSCs), provide a new cell source for regenerative medicine, disease modeling, drug discovery, and preclinical toxicity screening. Understanding of the onset and the sequential process of hematopoietic cells from differentiated hPSCs will enable the achievement of personalized medicine and provide an in vitro platform for studying of human hematopoietic development and disease. During embryogenesis, hemogenic endothelial cells, a specified subset of endothelial cells in embryonic endothelium, are the primary source of multipotent hematopoietic stem cells. In this review, we discuss current status in the generation of multipotent hematopoietic stem and progenitor cells from hPSCs via hemogenic endothelial cells. We also review the achievements in direct reprogramming from non-hematopoietic cells to hematopoietic stem and progenitor cells. Further characterization of hematopoietic differentiation in hPSCs will improve our understanding of blood development and expedite the development of hPSC-derived blood products for therapeutic purpose.

References

Apr 16, 1996·Proceedings of the National Academy of Sciences of the United States of America·Q WangN A Speck
May 1, 1996·Stem Cells·R AuerbachL Lu
May 9, 1998·Proceedings of the National Academy of Sciences of the United States of America·G HahnE S Mocarski
Nov 6, 1998·Science·J A ThomsonJ M Jones
Jul 6, 2000·Experimental Hematology·A M Lichanska, D A Hume
Apr 11, 2001·Proceedings of the National Academy of Sciences of the United States of America·J PalisM C Yoder
Aug 10, 2001·Experimental Hematology·J Palis, M C Yoder
Sep 6, 2001·Proceedings of the National Academy of Sciences of the United States of America·D S KaufmanJ A Thomson
Mar 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Shulamit LevenbergRobert Langer
Jun 22, 2002·The Journal of Immunology : Official Journal of the American Association of Immunologists·Takashi YahataTomomitsu Hotta
Sep 6, 2005·Experimental Hematology·Changwon ParkKyunghee Choi
Sep 6, 2005·Experimental Hematology·Michael J Ferkowicz, Mervin C Yoder
Jan 18, 2006·Stem Cells·Kristian M BowlesRoger A Pedersen
Mar 1, 1917·Proceedings of the National Academy of Sciences of the United States of America·H E Jordan
Jul 18, 2006·Proceedings of the National Academy of Sciences of the United States of America·Zoran GalicJerome A Zack
Apr 28, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jun CaiHongkui Deng
Oct 27, 2007·Proceedings of the National Academy of Sciences of the United States of America·John E PimandaBerthold Göttgens
Nov 22, 2007·Science·Junying YuJames A Thomson
Jan 22, 2008·Nature Immunology·Elaine Dzierzak, Nancy A Speck
Mar 22, 2008·The Journal of Clinical Investigation·Xiao-Bing ZhangHans-Peter Kiem
Mar 29, 2008·Cell Stem Cell·Ravindra MajetiIrving L Weissman

❮ Previous
Next ❯

Citations

Feb 6, 2016·Cellular and Molecular Life Sciences : CMLS·Emily Gritz, Karen K Hirschi
Jun 14, 2016·Stem Cells International·Padma Priya SivanSuresh Kumar
Oct 14, 2017·Arteriosclerosis, Thrombosis, and Vascular Biology·Yang LinMervin C Yoder
Feb 14, 2017·Stem Cells Translational Medicine·Aurelie BedelSandrine Dabernat
Sep 8, 2018·International Journal of Molecular Sciences·Hidenori TaniMasaki Ieda
Dec 18, 2020·Frontiers in Cell and Developmental Biology·Pedro SecoAna Teresa Tavares
May 11, 2021·Advanced Biology·Hayk MnatsakanyanPatricia Rico
May 28, 2021·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·A Vergès-CastilloC Pendon
Jul 3, 2021·Journal of Personalized Medicine·Julia DahlkeAxel Schambach

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adult Stem Cells

Adult stem cells reside in unique niches that provide vital cues for their survival, self-renewal, and differentiation. They hold great promise for use in tissue repair and regeneration as a novel therapeutic strategies. Here is the latest research.

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.